These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18370319)

  • 1. The "reverse capture" autoantibody microarray : an innovative approach to profiling the autoantibody response to tissue-derived native antigens.
    Ehrlich JR; Tang L; Caiazzo RJ; Cramer DW; Ng SK; Ng SW; Liu BC
    Methods Mol Biol; 2008; 441():175-92. PubMed ID: 18370319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'reverse capture' autoantibody microarray: a native antigen-based platform for autoantibody profiling.
    Ehrlich JR; Qin S; Liu BC
    Nat Protoc; 2006; 1(1):452-60. PubMed ID: 17406268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling.
    Qin S; Qiu W; Ehrlich JR; Ferdinand AS; Richie JP; O'leary MP; Lee ML; Liu BC
    Proteomics; 2006 May; 6(10):3199-209. PubMed ID: 16596707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.
    Gagnon A; Kim JH; Schorge JO; Ye B; Liu B; Hasselblatt K; Welch WR; Bandera CA; Mok SC
    Clin Cancer Res; 2008 Feb; 14(3):764-71. PubMed ID: 18245537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native antigen fractionation protein microarrays for biomarker discovery.
    Caiazzo RJ; O'Rourke DJ; Barder TJ; Nelson BP; Liu BC
    Methods Mol Biol; 2011; 723():129-48. PubMed ID: 21370063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A native antigen "reverse capture" microarray platform for autoantibody profiling of prostate cancer sera.
    Ehrlich JR; Caiazzo RJ; Qiu W; Tassinari OW; O'Leary MP; Richie JP; Liu BC
    Proteomics Clin Appl; 2007 May; 1(5):476-85. PubMed ID: 21136699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulomics : a serum autoantibody-based platform for transcription factor profiling.
    Tassinari OW; Aponte M; Caiazzo RJ; Liu BC
    Methods Mol Biol; 2008; 441():163-73. PubMed ID: 18370318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarrays.
    Gunawardana CG; Memari N; Diamandis EP
    Clin Biochem; 2009 Mar; 42(4-5):426-9. PubMed ID: 19094976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers.
    Miller JC; Zhou H; Kwekel J; Cavallo R; Burke J; Butler EB; Teh BS; Haab BB
    Proteomics; 2003 Jan; 3(1):56-63. PubMed ID: 12548634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel antibody microarray format using non-covalent antibody immobilization with chemiluminescent detection.
    Usui-Aoki K; Shimada K; Koga H
    Mol Biosyst; 2007 Jan; 3(1):36-42. PubMed ID: 17216054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplexed protein analysis using spotted antibody microarrays.
    Haab BB; Zhou H
    Methods Mol Biol; 2004; 264():33-45. PubMed ID: 15020778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody microarrays for native toxin detection.
    Rucker VC; Havenstrite KL; Herr AE
    Anal Biochem; 2005 Apr; 339(2):262-70. PubMed ID: 15797567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer.
    Tang L; Yang J; Ng SK; Rodriguez N; Choi PW; Vitonis A; Wang K; McLachlan GJ; Caiazzo RJ; Liu BC; Welch WR; Cramer DW; Berkowitz RS; Ng SW
    Eur J Cancer; 2010 Jan; 46(1):170-9. PubMed ID: 19926475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cancer protein microarray platform using antibody fragments and its clinical applications.
    Song S; Li B; Wang L; Wu H; Hu J; Li M; Fan C
    Mol Biosyst; 2007 Feb; 3(2):151-8. PubMed ID: 17245494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens.
    Draghici S; Chatterjee M; Tainsky MA
    Expert Rev Mol Diagn; 2005 Sep; 5(5):735-43. PubMed ID: 16149876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies.
    Chruscinski A; Huang FY; Ulndreaj A; Chua C; Fehlings M; Rao V; Ross HJ; Levy GA
    J Vis Exp; 2016 Sep; (115):. PubMed ID: 27685156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of a microarray sandwich-ELISA against hINF-gamma on a modified nitrocellulose membrane.
    Reck M; Stahl F; Walter JG; Hollas M; Melzner D; Scheper T
    Biotechnol Prog; 2007; 23(6):1498-505. PubMed ID: 17894469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays.
    Chen S; LaRoche T; Hamelinck D; Bergsma D; Brenner D; Simeone D; Brand RE; Haab BB
    Nat Methods; 2007 May; 4(5):437-44. PubMed ID: 17417647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients.
    Kalniņa Z; Siliņa K; Meistere I; Zayakin P; Rivosh A; Abols A; Leja M; Minenkova O; Schadendorf D; Linē A
    J Immunol Methods; 2008 May; 334(1-2):37-50. PubMed ID: 18314130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring cDNA phage display for autoantibody profiling in the serum of multiple sclerosis patients: optimization of the selection procedure.
    Govarts C; Somers K; Hupperts R; Stinissen P; Somers V
    Ann N Y Acad Sci; 2007 Aug; 1109():372-84. PubMed ID: 17785326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.